Cargando…

A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment

Formyl peptide receptor-like 1 inhibitor (FLIPr), an Fcγ receptor (FcγR) antagonist, can be used as a carrier to guide antigen-FLIPr fusion protein to FcγR then enhances antigen-specific immune responses. Survivin, a tumor-associated antigen, is over-expressed in various types of human cancer. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chiao-Chieh, Chiang, Chen-Yi, Liu, Shih-Jen, Chen, Hsin-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301409/
https://www.ncbi.nlm.nih.gov/pubmed/34356870
http://dx.doi.org/10.3390/biomedicines9070806

Ejemplares similares